Schroder Real Estate Inv... Share Discussion Threads

[brwo349] 23/11/2020 16:39

Flipping heck, that's a 0.85p difference. Big deal!

[chucko1] 23/11/2020 16:32

... but I never sold any at 40!! A lot of this stuff is for the medium term. Dividends will increase and I don't want to miss the big jump days as the expectation of this firms.

[skyship] 23/11/2020 16:26

I too bought today; bought back the stock sold at around the 40p level. Sadly was out all morning with a hospital appt, so missed the mid-morning cheap stock. Though if I'd been in first thing I might have paid more than the 37.10p actually paid!

chucko - 36.25p - well done you...

[my retirement fund] 23/11/2020 15:42

spooky action at a distance here

[spectoacc] 23/11/2020 14:56

I'd argue the current price prices in the terrible recession - anything less & we're quids in ;)

[flyer61] 23/11/2020 14:52

Maybe...but I have topped up today.

[chucko1] 23/11/2020 13:39

In fact, I sold a few RGL (up 40% the past 2 weeks or so) to buy SREI (up 10-15%). There may be some desperate, needy or stupid sellers of SREI out there, but I can't stop that. And if it ends up that I am benefitting from the losses the investors in these idiotic funds are suffering - too bad.

What is not obvious about how good a risk-reward SREI was at 30p, and perhaps even more so now given the news flow? Maybe a terrible recession next year?

[spectoacc] 23/11/2020 13:30

Been buying too, it's "risk on" now, don't want to be left in cash.

Interesting thing will be when they decide to buy back again - seen no evidence of it as yet, but it'll make for a floor.

[chucko1] 23/11/2020 13:26

I love Quavers - but I like buying this at 36.25p even more (relative to the prices of many other REITs). Did quite a bit there this morning.

[sphere25] 23/11/2020 12:40

Blooming hek, made a right bodge job of that second buy just under 40p. Award and ceremony please :-)

You'd think all dips would eventually get bought up in this market but the bulls gave up here purely on grounds of the number 40.

40p has been a key technical battleground and there was at least one buyer in size who kept coming in on the bid at 40p last week to buy in icebergs of just over 4k. The market however kept selling, and when it realised that a psychological number wasn't going to break, just ended up with this almost mini-capitulation down to 36.7p on nothing volume.

It's always a fascinating watch these key battlegrounds, akin to squares on a chessboard where control leads to more progressive moves. In this instance, had bulls taken control of the 40p square, the set up would have been to push on nicely into the mid 40's imo.

Nonetheless, it's more of a waiting game now, and seen as I'm a boring git who watches key battleground price movements, party at mine at some point next year?

I have Quavers!

(Please don't say you love Quavers :-) )

[hugepants] 23/11/2020 10:23

Looks like someone wants out even with great news on Oxford vaccine today. At 36.2p to buy I make the discount 37.5% and yield 6.4% (goes ex quarterly div on thursday).

[skyship] 21/11/2020 15:46

Q. I opened a CFD a/c quite recently. My intention being to have a trading a/c capable of shorting. In actual fact I've traded 95% on the bull tack - 100% in REITs.

Irrelevant. My question is: Does anyone else have a CFD a/c; and if so, could you say what commission you pay/trade? I'm being charged £15 by Accendo - a sum which compares unfavourably with my a/cs with You~Invest (£4.95) & IDealing (£9.95).

[flyer61] 21/11/2020 14:41

Noticed as well Skyship. Like the volatility as it makes it an interesting share to trade. At a circa 6% yield I'm happy to take another nibble at these prices. XD is 26 Nov.

[skyship] 21/11/2020 14:14

So, what do we make of:

# the apparent lack of renewed buybacks just yet
# the sell-off near the close, all the way back to 37.35p

Personally I had to miss the last 30mins of trading - returned at 4:28 - too late to buy back into some of the trading stock sold at 40p and just under. Hospital appt 1st thing Monday, so will miss again...though will try with a limit order.

At 37.5p the discount is back up to 35.3%. Perhaps that will stimulate the buybacks again...

[hindsight] 19/11/2020 18:28

Thank you for reply SpetoAcc and others on vaccines. Personally awaiting the Ox/Azn with fingers crossed, atleast the fda have given them a once over already

[spectoacc] 19/11/2020 14:52

Thanks @gco1133a, saw the 94%, hadn't seen that someone in the vaccine group had got it badly.

Do they have any idea yet if the vaccinated lot can still spread it?

Pfizer one fails on the -80 degrees if nothing else - Moderna way better in that regard.

[gco1133a] 19/11/2020 14:50

Re Pfizer actually more data was released yesterday

1. 170 cases with 95% efficacy 8 in vaccinated group162 in placebo group
2. 94% efficiacy in over 65

5/6. true of all the vaccines so far
7. one person got it badly in the vaccine group

[skyship] 19/11/2020 13:57

Flyer - "What's next?" Well, as so often happens, you take a few profits and are left with the problem of re-investment.

CASH is of course a perfectly acceptable holding in its own right; but I choose at the moment not to be 25% cash.

I also choose not to buy into more REITs just now; though the way things move nowadays that could change very quickly!

For me I have always concentrated my portfolio in two VALUE investment company sectors - REITS & Private Equity.

So, part of my reinvestment over the past week has been into the PE sector. JPEL & NBPE. The former jumped yesterday on good portfolio news, so give that a pass at the moment; but the latter looking really good value versus peers @ 1052p on a 28.8% discount and 4.28% yield.

A good presentation on NBPE published yesterday and linked in my post on The Private Equity thread:

[spectoacc] 19/11/2020 13:03

@hindsight - where to begin! (And sorry for OT).

1. The sample size. Dosed c.40k, great. But instead of waiting for the planned 140 positives to release the result, they released it when they had 94 of them. 94 is not statistically great.
2. No indication of ages - little use if it protects mainly the young, when it's only going to be given to the elderly to start wth
3. 40m doses by the end of the year - great - but needs two shots, so 20m people. 1.4bn by the end of next year - 700m people - less than 1/10th of the world's population. Don't know about you, but I'd be hoping for herd immunity well before Dec 2021.
4. -80 degrees. This alone makes it almost unusable for a mass vaccination programme
5. No idea how long immunity lasts
6. No idea if it stops you getting/spreading it, or merely lessens the symptoms
7. No details on whether the few who did still get who'd had the vaccine, got it badly
8. Pfizer CEO "Great day for humanity" slotted 60% of his shareholding on the day of the announcement - just as an aside ;)

There's more but you get the gist.

The Moderna vaccine looks considerably better, if only for storage temperature (more iced cream than specialist gear), tho still has a few flaws. As @chucko1 says - the Oxford one looking positive. That one is the game changer - the others are backstops.

[clausentum] 19/11/2020 13:02

Although the vaccines seem to be effective I think people are being over optimistic on timescale. Once NHS staff, carers and over 60yrs have been vaccinated there should be a dramatic fall in the number of deaths, but the elderly are not the main work force. There will still be spread through the bulk of the working population. It is only when the bulk of ordinary workers are vaccinated that the virus should find it difficult to spread and the economy can get back to near normal. How long will it take to vaccinate all the 20-60 yrs old who want it? I think May is achievable. Then we will know how many still have jobs, and how much of the economy remains.

[chucko1] 19/11/2020 12:47

Even though Oxford/AZN only supplied additional details about Phase 2 this morning, it is once again congruent with the idea that these new technologies are likely to have a highly significant effect on the journey COVID is trying to take.

I read into the Ox/AZN statement that their academic angle in of itself is highly significant, let alone the more here and now concerns. That there is no difference between theoretical outcomes between young and old using one/any/all of these new methods might be viewed as one of the larger medical leaps when there is time to reflect.

Stick with stronger balance sheets so that the respective stocks are still there to enjoy the benefits, whenever they (the benefits) get to acceleration mode!

[hindsight] 19/11/2020 12:26

SpectoAcc, why do you say Pfizer news naff ?, thanks

[my retirement fund] 19/11/2020 11:32

This is still looking strong, must be a pretty good chance of it pushing on back to 50p without any sensible pausing and pulling back opportunity to reload.

[spectoacc] 19/11/2020 07:04

Nothing wrong with taking profits but the money has to go somewhere, & IMO the risk now is to the upside - the Oxford vaccine news could come at anytime, and the (naff) Pfizer & (decent) Moderna news points to at least possible success. Add in EU deal (or not) & Santa rally, & I'm inclined to stay invested.

So I think @Sphere25 may have it right. But bets are there to be placed.

[flyer61] 18/11/2020 22:01

So what’s next SKYSHIP (besides me buying ,you a beer or two😃) wait for a pull back? Still running the slide rules over BREI.